Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6708
Source ID: NCT02674893
Associated Drug: Liraglutide
Title: Effect of Victoza on Dietary Preferences and Habit in Patients With Type 2 Diabetes
Acronym: GLP1 et Goût
Status: TERMINATED
Study Results: NO
Results:
Conditions: Type 2 Diabetes|Overweight
Interventions: DRUG: Liraglutide|OTHER: Observation alone
Outcome Measures: Primary: Modifications in wanting, Up to 3 months | Secondary: Modifications in gustatory performance, Until 3 months|Modifications in liking, Until 3 months|Modifications in salivation following the presentation of foods, Until 3 months|Modifications in optimal preferences for sweet and fatty tastes, Until 3 months|Anthropometric modifications, Until 3 months
Sponsor/Collaborators: Sponsor: Centre Hospitalier Universitaire Dijon
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 48
Study Type: INTERVENTIONAL
Study Designs: Allocation: |Intervention Model: PARALLEL|Masking: |Primary Purpose:
Start Date: 2014-02-04
Completion Date: 2016-08-31
Results First Posted:
Last Update Posted: 2019-09-06
Locations: CHU de DIJON, Dijon, 21079, France
URL: https://clinicaltrials.gov/show/NCT02674893